Diversified Healthcare Trust

NasdaqGS:DHCN.L Stock Report

Market Cap: US$938.8m

Diversified Healthcare Trust Past Earnings Performance

Past criteria checks 0/6

Diversified Healthcare Trust's earnings have been declining at an average annual rate of -30%, while the REITs industry saw earnings growing at 18.3% annually. Revenues have been growing at an average rate of 5.1% per year.

Key information

-30.02%

Earnings growth rate

-30.26%

EPS growth rate

REITs Industry Growth19.39%
Revenue growth rate5.12%
Return on equity-6.44%
Net Margin-11.64%
Last Earnings Update30 Sep 2020

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown

How Diversified Healthcare Trust makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

NasdaqGS:DHCN.L Revenue, expenses and earnings (USD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 201,503-175320
30 Jun 201,365-97340
31 Mar 201,216-109360
31 Dec 191,040-88370
30 Sep 191,069-155290
30 Jun 191,092-80500
31 Mar 191,10881710
31 Dec 181,117287860
30 Sep 181,1104701310
30 Jun 181,0984591200
31 Mar 181,0863511140
31 Dec 171,0751481040
30 Sep 171,070125700
30 Jun 171,068119620
31 Mar 171,064142510
31 Dec 161,058141470
30 Sep 161,051108450
30 Jun 161,043118430
31 Mar 161,029116430
31 Dec 15999125430
30 Sep 15961165430
30 Jun 15923164430
31 Mar 15882164410
31 Dec 14845162390
30 Sep 14815193360
30 Jun 14786192340
31 Mar 14766188320

Quality Earnings: DHCN.L is currently unprofitable.

Growing Profit Margin: DHCN.L is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: DHCN.L is unprofitable, and losses have increased over the past 5 years at a rate of 30% per year.

Accelerating Growth: Unable to compare DHCN.L's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: DHCN.L is unprofitable, making it difficult to compare its past year earnings growth to the REITs industry (37.9%).


Return on Equity

High ROE: DHCN.L has a negative Return on Equity (-6.44%), as it is currently unprofitable.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2021/01/04 03:30
End of Day Share Price 2021/01/04 00:00
Earnings2020/09/30
Annual Earnings2019/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Diversified Healthcare Trust is covered by 15 analysts. 8 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Andrew BabinBaird
Joshua DennerleinBofA Global Research
Bryan MaherB. Riley Securities, Inc.